Skip Navigation

Letermovir Prophylaxis for Cytomegalovirus in Pediatric Hematopoietic Cell Transplantation

Brief Summary

Type:
Hematologic - Other

Study Type:
Prevention

Phase:
III

ClinicalTrials.gov Identifier:
NCT05711667

Study #:
CMH - ACCL1932

Start Date:
Oct 14, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05711667

View Complete Trial Details & Eligibility at ClinicalTrials.gov